New York 2025 Session Status: Introduced

A860 — Establishes the "Maternal Health, Dignity and Consent act"

Last action — In Assembly Committee

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Assembly
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Assembly. Introduced January 08, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

In plain language

The bill regulates drug testing of pregnant or postpartum individuals and newborns.

This bill prohibits testing for drugs, alcohol, or cannabis in pregnant or postpartum individuals and newborns without consent or in emergencies. It aims to protect the rights and dignity of these individuals during medical care.

What this means for you
  • Families: This means that families can expect more autonomy regarding medical testing during pregnancy and after childbirth.

Summary

Prohibits drug, cannabis or alcohol testing of pregnant or postpartum individuals and newborns unless the individual consents and it is within the scope of medical care, or the testing is necessary for a medical emergency.

Bill Text

Action History

  1. REPORTED REFERRED TO RULES

  2. PRINT NUMBER 860A

  3. AMEND (T) AND RECOMMIT TO CODES

  4. REPORTED REFERRED TO CODES

  5. REFERRED TO HEALTH

  6. REFERRED TO HEALTH

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 218 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (218)

218 members have not signed on to this bill.

Show all 218 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

civil-rights healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does A860 do?
Prohibits drug, cannabis or alcohol testing of pregnant or postpartum individuals and newborns unless the individual consents and it is within the scope of medical care, or the testing is necessary for a medical emergency.
Who sponsors A860?
A860 is sponsored by Linda Rosenthal.
What is the current status of A860?
This bill has been introduced in the Assembly. Introduced January 08, 2025. It must pass committee before a floor vote.
Where can I track A860?
Track A860 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on A860

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of A860

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →